The week at Retraction Watch featured the results of a massive replication study, yet another retraction for Diederik Stapel, and a messy situation at PLOS. Here’s what was happening elsewhere:
This week, we marked the fifth anniversary of Retraction Watch with the announcement of a generous new grant. We also covered the retraction of a slew of papers in a journal plagued by problems. Here’s what was happening elsewhere:
Who has the most retractions? Here’s our unofficial list (see notes on methodology), which we’ll update as more information comes to light: Joachim Boldt (220) See also: Editors-in-chief statement, our coverage Yoshitaka Fujii (172) See also: Final report of investigating committee, our reporting, additional coverage Hironobu Ueshima (124) See also: our coverage Yoshihiro Sato (122) … Continue reading The Retraction Watch Leaderboard
This week at Retraction Watch featured a hotly debated guest post from Leonid Schneider and two ORI findings. Here’s what was happening elsewhere:
Another busy week at Retraction Watch, but there was lots happening elsewhere, too:
Another busy week at Retraction Watch, with Harvard dominating the news about scientific misconduct here and elsewhere. Here’s what else was happening around the web:
Retraction Watch has learned that The Leadership Quarterly, a management journal published by Elsevier, plans to retract five papers by a Florida researcher poised to “rock” the field — but probably not quite in the way a press release intended — whose findings in the articles were questioned by readers. The scholar, Fred O. Walumbwa, … Continue reading Leadership journal to retract five papers from FIU scholar
Alirio Melendez, who has already retracted five papers and was found by one of his former universities to have committed misconduct on more than 20, has three more retractions. Here’s the notice for “Antisense Knockdown of Sphingosine Kinase 1 in Human Macrophages Inhibits C5a Receptor-Dependent Signal Transduction, Ca2+ Signals, Enzyme Release, Cytokine Production, and Chemotaxis,” … Continue reading And then there were eight: Three more retractions for Alirio Melendez, all in the Journal of Immunology
In baseball, it’s three strikes and you’re out. In Nature, apparently, you can stay at the plate after three swings-and-misses. That’s what we concluded from a Corrigendum in last week’s issue, for “CD95 promotes tumour growth,” originally published in May 2010 and now corrected not once, not twice, but three times. Here was the first … Continue reading The Nature paper that required three corrections
A new retraction — his fifth — in the Journal of Immunology for Alirio Melendez, formerly of the National University of Singapore, the University of Glasgow, and the University of Liverpool, sheds some light on the results of an investigation by one of the universities. Last month, a Glasgow spokesperson told Nature that the university’s … Continue reading Fifth Alirio Melendez retraction offers clues about University of Glasgow misconduct findings